All dengue virus articles
-
NewsInvasive mosquito species detected in east London
The UK Health Security Agency (UKHSA) is undertaking enhanced surveillance and trapping activities following the detection of invasive Aedes aegypti mosquitoes and larvae at nearby residential properties in east London.
-
NewsNIH grants $2.8M to develop tools for study of mosquito-microbe interactions
Researchers will use the funding to develop new tools to investigate the genetics underpinning the relationships between mosquitoes and various microbes.
-
NewsStudy reveals dengue virus can infect immune cells meant to fight disease
Researchers have discovered that dengue virus can infect and replicate inside memory B cells, immune cells traditionally understood to help protect the body from infection. It’s a previously unrecognized way the virus may evade immune defenses.
-
NewsBrazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment
Following a licensing agreement signed between the Serum Institute of India (SII) and DNDi, a Phase III clinical trial is expected to begin early next year, with the aim of developing a safe, effective, and globally accessible therapeutic for dengue.
-
NewsPrize winner’s research reveals microbiota’s hidden role in in mosquito-borne disease
For his work in revealing the hidden role of the microbiota in mosquito-borne disease, Yibin Zhu is the winner of the 2026 Noster NOSTER & Science Microbiome Prize. Microbiota from both the hosts and vectors can either promote or suppress virus transmission, depending on where they act in the transmission cycle.
-
NewsDengue vaccine shows favorable safety profile in travellers from non-endemic regions
A prospective study of more than 1,000 people vaccinated with TAK-003 in Catalonia found no serious adverse events and provides new evidence on the vaccine’s short-term safety in travelers.
-
NewsCommentary: Dengue viral infection and associated liver disease
A new commentary highlights the time course of serological and liver enzyme elevations in mild versus severe dengue, emphasizes early recognition of progression to acute liver failure, and reviews current vaccination and prevention strategies.
-
NewsNew research reveals cell proteins that drive severe viral infections
Researchers have identified two human cell proteins, NUP98 and NUP153, that play a crucial role in how viruses such as tick-borne encephalitis virus (TBEV), West Nile virus, and dengue virus replicate in the body.
-
NewsClimate change is fueling disease outbreaks
Researchers analyzed the connection between a cyclone in Peru and a massive outbreak of dengue fever, a mosquito-borne viral disease that can cause fever, rash, and life-threatening symptoms like hemorrhage and shock. Their findings reveal that warmer, wetter weather linked to climate change is making disease epidemics more likely.
-
NewsNew dashboard helps predict and plan for disease outbreaks
When infectious diseases surge, response often comes down to whether communities can position the right people and supplies before case counts spike. Researchers have designed a new platform to translate academic disease forecasting into actionable guidance for decision-makers.
-
NewsSilent dengue infections may hold clues to future vaccine design, study finds
Researchers report the first single-cell immune atlas of asymptomatic dengue, offering a rare look at how the immune system can defeat the virus without triggering illness. The work could help guide the design of safer and more effective dengue vaccines.
-
NewsNature’s 10: Ten people who shaped science in 2025
Microbiologists and scientists tackling infectious diseases are among Nature’s annual list of ten people at the heart of some of the biggest science stories of 2025.
-
NewsIn the midst of a global dengue epidemic, Wolbachia kept a Brazilian city safe
In the middle of the world’s worst global dengue epidemic, a city in Brazil was effectively protected by an innovative program that introduced the bacterium Wolbachia into the local mosquito population, lowering the rate of dengue by almost 90 per cent.
-
NewsQdenga vaccine shows effectiveness against dengue under real-world conditions during Brazil’s 2024 outbreak
An international team of researchers has demonstrated that the tetravalent dengue vaccine Qdenga provides significant protection against the disease under real-world conditions, during the large 2024 epidemic in São Paulo, Brazil.
-
NewsDespite increase in U.S. cases, worry about West Nile virus remains low
Despite this season’s growing number of cases, relatively few Americans worry about becoming infected by West Nile or by dengue fever, another mosquito-borne illness, according to a survey of nearly 1,700 U.S. adults.
-
NewsWarming climate drives disease surge, study shows
Projections suggest future warming could raise dengue incidence by 49%–76%, depending on emissions scenarios, if other factors remain constant. Cooler areas are expected to see the biggest increases, while hotter locations may experience slight declines.
-
NewsStudy reveals how dengue rewires the immune system, reshaping vaccine response
Just as a computer’s operating system can be rewritten after a major update, dengue infection can ‘re-programme’ the body’s immune system, leaving a long-lasting genetic imprint that influences how people respond to future infections—an effect not seen with vaccination.
-
NewsNew ECDC weekly reports and guidance to tackle mosquito-borne diseases across Europe
As Europe enters this year’s mosquito season, ECDC has launched a new series of weekly epidemiological surveillance updates and public health guidance on mosquito-borne diseases.
-
NewsComputer-identified antiviral drug candidates confirmed by lab experiments
An interdisciplinary research team has identified two antiviral drug candidates effective against a wide range of viruses. The study demonstrates how combining computer-aided modeling with laboratory validation can speed up the development of new antiviral drugs.
-
NewsPediatric investigation review discusses the challenges, innovations, and future directions in dengue vaccine development
A new review discusses the current status and implications of dengue vaccines like CYD-TDV, TAK-003, and Butantan-DV while exploring the challenges in Dengue vaccine development like ADE, and proposes future directions in this field.